1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Olfactory Nerve Diseases: new trials by email Literature Review of Olfactory Nerve Diseases trials Research Report on Olfactory Nerve Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors docetaxel, vandetanib, proteomic profiling - Breast Cancer, Head and Neck Cancer | Phase 1 | Withdrawn | SWOG Cancer Research Network | 2008-09-01 | 2017-04-24 |
Adenocarcinoma, Follicular (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Medullary (1) · Carcinoma, Non-Small-Cell Lung (1) · Esthesioneuroblastoma, Olfactory (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Prostatic Neoplasms (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Thyroid Cancer, Papillary (1) · Thyroid Carcinoma, Anaplastic (1) · Thyroid Neoplasms (1)
Adenocarcinoma (1) · Adenocarcinoma, Papillary (1) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Squamous Cell (1) · Cranial Nerve Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Lung Diseases (1)
Docetaxel (1) · vandetanib (1)
SWOG Cancer Research Network (1)
Monica Mita, MD (1)